Objective: To allow adequate representation of clinical trial data in OMOP.
First use case: To convert clinical trial data in CDISC SDTM format to OMOP, with a view to allowing trial planning optimization.
Approach: We advocate minimum changes to the OMOP CDM and Standardized Vocabularies because we want to ensure minimum impact on OHDSI tools like Atlas, whilst providing a value-add SDTM-to-OMOP conversion with minimum data loss. We have proposed conventions introducing new concepts and modifiers, but no new CDM tables; and providing guidance for ETL developers where appropriate. Our proposals are built on OMOP CDM v6 and the Oncology extension, with v5.3.1 backward compatibility.
- Proposals submitted to the OHDSI community in July 2020.
- Currently applying our proposed conventions to the PHUSE database (a synthetic SDTM database).
Conventions proposal submitted to OHDSI
Group GitHub repository
Schedule: Biweekly calls on Fridays, 3pm UK time (10am Eastern) on Teams here
|Q4 2020||Q3 2020||Q2 2020||Q1 2020|
|02 Oct||18 Sep||26 Jun||20 Mar|
|13 Nov||04 Sep||22 May||06 Mar (partial)|
|11 Dec (partial)||21 Aug||15 May||07 Feb|
|14 Aug||01 May||10 Jan|
Q4 2019 06 Dec - initial presentations from the Hyve, Medidata and Odysseus
Want to contribute to the group? Email email@example.com